Biophytis S.A. (BPTSY)
USD 3.05
(0.0%)
USD 3.05
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -14.33 Million EUR | 38.74% |
| 2022 | -28.05 Million EUR | 23.81% |
| 2021 | -36.81 Million EUR | -86.87% |
| 2020 | -19.7 Million EUR | 5.0% |
| 2019 | -20.73 Million USD | -3.45% |
| 2018 | -20.04 Million USD | -42.73% |
| 2017 | -14.04 Million USD | -33.02% |
| 2016 | -10.55 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -2368.62 USD | 43.78% |
| 2024 Q2 | -2351.37 USD | 0.0% |
| 2023 Q4 | -9.13 Million USD | -221268.94% |
| 2023 FY | -17.18 Million EUR | 38.74% |
| 2023 Q1 | -3538.34 USD | 99.97% |
| 2023 Q3 | -4127.81 USD | 99.95% |
| 2023 Q2 | -8.04 Million USD | -227295.85% |
| 2022 FY | -28.05 Million EUR | 23.81% |
| 2022 Q2 | -15.87 Million USD | 0.0% |
| 2022 Q4 | -12.31 Million USD | 0.0% |
| 2021 Q2 | -15.29 Million USD | 0.0% |
| 2021 Q4 | -21.42 Million USD | 0.0% |
| 2021 FY | -36.81 Million EUR | -86.87% |
| 2020 FY | -19.7 Million EUR | 5.0% |
| 2020 Q4 | -9.51 Million USD | 0.0% |
| 2020 Q2 | -10.15 Million USD | 0.0% |
| 2019 Q4 | -7.95 Million USD | 0.0% |
| 2019 FY | -20.73 Million USD | -3.45% |
| 2018 FY | -20.04 Million USD | -42.73% |
| 2017 FY | -14.04 Million USD | -33.02% |
| 2016 FY | -10.55 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 80.034% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 391.629% |
| SQZ Biotechnologies Company | -75.82 Million USD | 81.097% |
| Evofem Biosciences, Inc. | -17.84 Million USD | 19.69% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 117.511% |
| Mesoblast Limited | -84.14 Million USD | 82.967% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -833.108% |
| Genus plc | 6.4 Million USD | 323.953% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 247.119% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -1438.899% |
| Marizyme, Inc. | -34.08 Million USD | 57.951% |
| ContraFect Corporation | -56.88 Million USD | 74.805% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | -71.653% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | -214.684% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -922.332% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -402.823% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -421.041% |
| MultiCell Technologies, Inc. | -722.81 USD | -1982855.41% |
| Accustem Sciences Inc. | -3.74 Million USD | -282.579% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 75.703% |
| EV Biologics, Inc. | -483.06 Thousand USD | -2867.114% |
| Q BioMed Inc. | -3.44 Million USD | -315.978% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 504.887% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -3579.185% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -445.495% |
| Biomind Labs Inc. | -1 Million USD | -1319.667% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | -4.87 Million USD | -193.736% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | -115.598% |
| Skye Bioscience, Inc. | -13.67 Million USD | -4.836% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -621.528% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -47753.232% |
| Arch Therapeutics, Inc. | -5.04 Million USD | -184.132% |
| IMV Inc. | -38.67 Million USD | 62.937% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 9.683% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -641.64% |
| GB Sciences, Inc. | -1.42 Million USD | -909.005% |
| Alpha Cognition Inc. | -9.7 Million USD | -47.678% |
| HST Global, Inc. | -140.9 Thousand USD | -10071.957% |
| CSL Limited | 3.7 Billion USD | 100.387% |
| Halberd Corporation | -75.05 Thousand USD | -18997.935% |
| Enzolytics Inc. | -2.14 Million USD | -567.023% |
| Resverlogix Corp. | -12.74 Million USD | -12.425% |
| Affymax, Inc. | -15.04 Million USD | 4.739% |
| SYBLEU INC | -149.18 Thousand USD | -9507.856% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | -352.391% |
| argenx SE | -425.04 Million USD | 96.628% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 74.178% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -1272.893% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -807.522% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | -320.942% |
| AVAX Technologies, Inc. | 6.69 Million USD | 314.153% |
| Zenith Capital Corp. | -8.94 Million USD | -60.271% |
| Genscript Biotech Corporation | -415.79 Million USD | 96.553% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -82174.267% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -483.754% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -8256.97% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 73.927% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -394.028% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -1356.527% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -668.785% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -1041.162% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -614.949% |
| BioStem Technologies, Inc. | -7.77 Million USD | -84.253% |
| ONE Bio Corp. | 13.68 Million USD | 204.762% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -7797.622% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -973.286% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -1174.151% |
| Agentix Corp. | -1.37 Million USD | -944.865% |
| LadRx Corporation | -3.82 Million USD | -274.854% |
| Cell Source, Inc. | -4.32 Million USD | -231.372% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -3349.753% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -1986.469% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -1986.469% |
| NovAccess Global Inc. | -2.46 Million USD | -481.046% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -390.95% |
| Itoco Inc. | -919.14 Thousand USD | -1459.392% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | -238.169% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -1180.876% |
| Kadimastem Ltd | -3.04 Million USD | -371.441% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -5376.338% |
| CytoDyn Inc. | -18.05 Million USD | 20.628% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -56844.776% |
| Mobile Lads Corp. | -554.55 Thousand USD | -2484.618% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -6412.691% |
| Qrons Inc. | -643.67 Thousand USD | -2126.738% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -2438.058% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.22 Million USD | -542.77% |
| Rebus Holdings, Inc. | -664 Thousand USD | -2058.584% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -689.123% |
| International Stem Cell Corporation | -663 Thousand USD | -2061.84% |
| Bioxytran, Inc. | -3.82 Million USD | -275.195% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -27128.343% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -70367.06% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 60.478% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -785.847% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -1847.855% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | -360.72% |
| Neutra Corp. | -229.48 Thousand USD | -6145.697% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | 18.279% |
| PureTech Health plc | -146.19 Million USD | 90.196% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | 33.307% |
| IXICO plc | -1.43 Million USD | -897.425% |
| IntelGenx Technologies Corp. | -9.49 Million USD | -51.017% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 88.233% |
| CSL Limited | 3.81 Billion USD | 100.376% |
| Cellectis S.A. | -108.85 Million USD | 86.833% |